Korea's Green Cross Wins Bid To Supply Chicken Pox Vaccine to WHO
This article was originally published in PharmAsia News
Executive Summary
SEOUL - South Korea's leading vaccine maker Green Cross has won another round of international bidding to supply the World Health Organization's Pan American Health Organization with its chicken pox vaccine Suduvax worth $10.4 million
You may also be interested in...
Green Cross Becomes First Korean Pharma To Export Flu Vaccine
SEOUL - South Korea's vaccine producer Green Cross shipped its first batch of flu vaccine GCFlu to the World Health Organization's Pan American Health Organization June 8 in accordance with a $6 million deal signed in March.Noting that it is the first Korean pharma to export seasonal flu vaccine, Green Cross said it is to make the second and third shipments of the vaccine by the end of June
Green Cross Becomes First Korean Pharma To Export Flu Vaccine
SEOUL - South Korea's vaccine producer Green Cross shipped its first batch of flu vaccine GCFlu to the World Health Organization's Pan American Health Organization June 8 in accordance with a $6 million deal signed in March.Noting that it is the first Korean pharma to export seasonal flu vaccine, Green Cross said it is to make the second and third shipments of the vaccine by the end of June
Demand For A/H1N1 Vaccine Catapults Green Cross Into No. 2 Spot In Korea; Company Ramps Up Biosimilar Pipeline
SEOUL - Of the many local Korean pharmaceutical players, vaccine producer Green Cross was the biggest beneficiary of the A/H1N1 flu pandemic last year as increased demand for its vaccines triggered a remarkable upgrade in its rankings to the second-largest from its previous long-time position of No. 5